课题基金 / 基金详情

Synthesis and Optimization of the Aleutianamine Class of Alkaloids

Synthesis and Optimization of the Aleutianamine Class of Alkaloids
阿留申胺类生物碱的合成与优化
批准号:
10345968
负责人:
Mark T Hamann
金额:
$56.07万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-09-01 至 2026-06-30

项目摘要

项目成果

Mark T Hamann的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT There is a tremendous unmet need for effective synthesis methodologies and strategies for the construction of aleutianamine and other members of the discorhabdin class of natural products. This has significantly hindered the mechanistic, basic and applied science studies for this unique class of alkaloids which offers significant value in the control of a variety of diseases and clearly warrants additional basic research into the synthesis, mechanism of action and basic pharmacology. Natural Products (NPs) have played a key role as therapeutics for a variety of diseases and the data presented in this application reveals the tremendous potential for these molecules. After 25 years of studying marine organisms for new and innovative chemistry we have identified a single truly remarkable molecule called aleutianamine. Aleutianamine has been recovered from a Latrunculia sponge collected from the deep ocean off the coast of the Aleutian Islands by NOAA Alaska. We have exhaustively interrogated extracts for any detectable quantities of this molecule and the only remaining option to generate mechanistic and in vivo data is to first generate the drug through a reliable synthesis. This molecule is extremely unique chemically and is a member of two very rare groups of bioactive natural products including the iminoquinones and the thioalkaloids and is certain to be a product of the extreme conditions of these deep ocean environments where cold temperatures, high pressure, and anoxic conditions deplete of UV irradiation provides a unique environment for biosynthesis and rearrangement to form highly unusual molecules. Aleutianamine and other members of this class as well as their synthetic intermediates offer unique controls for a diversity of diseases including malaria, inflammation, viral diseases and cancer strongly supporting the development of strategies to provide consistent supply of the drug and approaches to the generation and diversification of the class. Due to the rare and limited supply of this molecule the specific aims of this program involve the development of synthesis methodologies using two different routes in addition to the isolation and characterization of starting materials and related molecules for SAR and investigations into alternative approaches involving biosynthetic starting materials for the construction and optimization of the molecule.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Synthesis and Optimization of the Aleutianamine Class of Alkaloids
Support for Graduate, PDF and New Faculty Presenters at the 2022 American Society of Pharmacognosy Meeting
Natural Product HCV Drugs from Rare Plant-Microbe Interactions
  • 批准号:
    8707979
  • 项目类别:
  • 资助金额:
    $30.64万
  • 财政年份:
    2012
  • 负责人:
    Mark T Hamann
  • 依托单位:
Natural Product HCV Drugs from Rare Plant-Microbe Interactions
  • 批准号:
    8912993
  • 项目类别:
  • 资助金额:
    $0.83万
  • 财政年份:
    2012
  • 负责人:
    Mark T Hamann
  • 依托单位:
海外基金